91 related articles for article (PubMed ID: 15452610)
1. Expression of surface lymphocyte markers in various courses of gastrointestinal tumors.
Oleinik EK; Shibaev MI; Oleinik VM
Bull Exp Biol Med; 2004 Apr; 137(4):385-8. PubMed ID: 15452610
[TBL] [Abstract][Full Text] [Related]
2. [Expression of lymphocyte activation markers in patients with gastrointestinal tumors at different stages].
Oleĭnik EK; Shibaev MI; Oleĭnik VM
Vopr Onkol; 2005; 51(5):571-4. PubMed ID: 16756013
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
[TBL] [Abstract][Full Text] [Related]
4. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
5. A case-control study on lymphocytic subsets in elderly bearing a gastroenteric cancer.
Nano M; Molaschi M; Scarafiotti C; Fonte G; Esposito E; Dal Corso HM; Grosso Roasenda G; Geuna M; Palestro G; Lale-Murix E
Panminerva Med; 1997 Mar; 39(1):6-11. PubMed ID: 9175414
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
[TBL] [Abstract][Full Text] [Related]
7. Correlation of altered blood albumin characteristics and lymphocyte populations to tumor stage in gastrointestinal cancer patients.
Kalnina I; Kurjane N; Kirilova E; Klimkane L; Kirilov G; Zvagule T
Cancer Biomark; 2010; 7(2):91-9. PubMed ID: 21178267
[TBL] [Abstract][Full Text] [Related]
8. [Cellular and intracellular markers of lymphocyte activation in patients with infiltrative pulmonary tuberculosis].
Mishin VIu; Pavliuk AS; Bela MV; Koval'chuk LV
Probl Tuberk; 1995; (4):45-8. PubMed ID: 7567872
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood lymphocyte phenotypes in patients with spondyloarthropathy.
Plonquet A; Gleizes A; Briot K; Maison P; Chevalier X; Farcet JP; Claudepierre P
Ann Rheum Dis; 2004 Apr; 63(4):467-8. PubMed ID: 15020352
[No Abstract] [Full Text] [Related]
10. The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes.
Plaeger S; Bass HZ; Nishanian P; Thomas J; Aziz N; Detels R; King J; Cumberland W; Kemeny M; Fahey JL
Clin Immunol; 1999 Feb; 90(2):238-46. PubMed ID: 10080836
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of interleukin-2 production and downregulation of IL-2 and transferrin receptors on rat splenic lymphocytes following PAG morphine administration: a role in natural killer and T cell suppression.
Gomez-Flores R; Weber RJ
J Interferon Cytokine Res; 1999 Jun; 19(6):625-30. PubMed ID: 10433363
[TBL] [Abstract][Full Text] [Related]
12. The kinetics and temporal expression of T-cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cells.
Chadburn A; Inghirami G; Knowles DM
Hematol Pathol; 1992; 6(4):193-202. PubMed ID: 1362727
[TBL] [Abstract][Full Text] [Related]
13. [The specific features of immune disorders in acute severe brain injury].
Epifantseva NN; Borshchikova TI; Surzhikova GS; Churliaev IuA; Dantsinger DG; Vialova VN; Purakhina SM
Anesteziol Reanimatol; 2009; (6):65-8. PubMed ID: 20099653
[TBL] [Abstract][Full Text] [Related]
14. Circulating lymphocyte subsets in pancreatic adenocarcinoma and their relationship to the stage of the disease.
Pezzilli R; Fabbri D; Imbrogno A; Morselli-Labate AM; Corinaldesi R
Pancreas; 2012 Aug; 41(6):976-8. PubMed ID: 22781914
[No Abstract] [Full Text] [Related]
15. CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression.
Sasada T; Kimura M; Yoshida Y; Kanai M; Takabayashi A
Cancer; 2003 Sep; 98(5):1089-99. PubMed ID: 12942579
[TBL] [Abstract][Full Text] [Related]
16. [Lymphocyte populations and subpopulations in peripheral blood of pregnant women with pre-eclampsia].
Dimitrakova-Dzhambazova E; Milchev N; Pavlov P; Dimitrakov D
Akush Ginekol (Sofiia); 2005; 44(1):40-4. PubMed ID: 15853011
[TBL] [Abstract][Full Text] [Related]
17. Lymphocytes subsets reference values in childhood.
Tosato F; Bucciol G; Pantano G; Putti MC; Sanzari MC; Basso G; Plebani M
Cytometry A; 2015 Jan; 87(1):81-5. PubMed ID: 25132325
[TBL] [Abstract][Full Text] [Related]
18. [The Influence of UV-Light on the Sub-Populational Composition and Expression of Membrane Markers of Lymphocytes of Donor Blood].
Artyukhov VG; Basharina OV; Zemchenkova OV; Ryazantsev SV
Radiats Biol Radioecol; 2016; 56(1):73-80. PubMed ID: 27245007
[TBL] [Abstract][Full Text] [Related]
19. Cellular immunity, peripheral blood lymphocyte count and pathological staging of tumours in the gastrointestinal tract.
Bone G; Lauder I
Br J Cancer; 1974 Sep; 30(3):215-21. PubMed ID: 4451626
[TBL] [Abstract][Full Text] [Related]
20. Raman spectroscopic modeling of early versus late T-lymphocyte activation via differential spectral detection of receptor expression.
Brown KL; Palyvoda OY; Auner GW; Gruber SA
J Immunol Methods; 2014 Dec; 415():31-5. PubMed ID: 25450257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
